SCHEMBL9423733

SCHEMBL9423733

CC(C)c1ccc(S(N)(=O)=O)cc1.[KH]

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 14/20 0.66
CA1 P00915 11/20 0.66
CA9 Q16790 10/20 0.66
CA12 O43570 10/20 0.66
ALDH1A1 P00352 3/20 0.62
CA7 P43166 6/20 0.56
CA5A P35218 5/20 0.56
CA5B Q9Y2D0 5/20 0.56
CA6 P23280 3/20 0.56
CA14 Q9ULX7 3/20 0.56
CA4 P22748 2/20 0.56
CA13 Q8N1Q1 2/20 0.56
USP2 O75604 1/20 0.56
TSHR P16473 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
AGO2 Q9UKV8 1/20 0.56
CA3 P07451 2/20 0.54
KDM4E B2RXH2 1/20 0.53
LMNA P02545 1/20 0.53
GAA P10253 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL84516 0.98 CA2 (0.68) CA2CA1CA9CA12ALDH1A1
Fluoride SCHEMBL28353367 0.95 CA2 (0.66) CA2CA1CA9CA12ALDH1A1
Hydrochloric Acid SCHEMBL3532247 0.95 CA2 (0.66) CA2CA1CA9CA12ALDH1A1
Benzenesulfonamide SCHEMBL9819524 0.83 CA2 (0.67) CA2CA1CA9CA12ALDH1A1
Sulfanilamide SCHEMBL27568655 0.82 CA2 (0.63) CA2CA1CA9CA12ALDH1A1
SCHEMBL8248221 0.82 ALDH1A1 (0.62) CA2CA1CA9CA12ALDH1A1
SCHEMBL1186051 0.82 ALDH1A1 (0.62) CA2CA1CA9CA12ALDH1A1
SCHEMBL1790668 0.82 ALDH1A1 (0.62) CA2CA1CA9CA12ALDH1A1
SCHEMBL672750 0.80 CA2 (1.00) CA2CA1CA9CA12CA7
SCHEMBL12112205 0.80 ALDH1A1 (0.60) CA2CA1CA9CA12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5292740-A Sulfonamides HOFFMANN-LA ROCHE INC. (US) 1994-03-08 US disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed